Adjuvant icotinib for resected EGFR-mutated stage II-IIIA non-small-cell lung cancer (ICTAN, GASTO1002): a randomized comparison study
辅助使用埃克替尼治疗切除的 EGFR 突变 II-IIIA 期非小细胞肺癌(ICTAN,GASTO1002):一项随机对照研究
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02358-w
Li, Ning; Ou, Wei; Cheng, Chao; You, Jian; Yang, Lin; Chen, Feng-Xia; Liang, Yi; Yang, Zhixiong; Wang, Bao-Xiao; Chang, Zeng-Hao; Lin, Yao-Bin; Yang, Weixiong; Xu, Feng; Ding, Guanggui; Chen, Xian-Shan; Hu, Ronggui; Li, Shujun; Jiang, Hao; Hu, Xin-Xin; Long, Hao; Wang, Si-Yu